Global Biopharmaceutical Stability Testing Market


GlobalMarketEstimates

Uploaded on Aug 2, 2022

Category Business

Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global Biopharmaceutical Stability Testing Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/biopharmaceutical-stability-testing-market-3889

Category Business

Comments

                     

Global Biopharmaceutical Stability Testing Market

Global Biopharmaceutical Stability Testing Market According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027. Intertek Group plc, Eurofins Scientific, Pacific Biolabs, SGS SA, Element Materials Technology, Almac Group, Merck KGaA, Catalent, Inc., Pace Analytical Life Sciences, Boston Analytical, Kemwell Biopharma, Curia Global, Inc., Thermo Fisher Scientific, Inc., Protagen Protein Services GmbH, Alcami Corporation, Inc., Symmetric s.r.o., LGM Pharma, and LabCorp, among others, are key players in the biopharmaceutical stability testing market. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in- depth TOC on “Global Biopharmaceutical Stability Testing Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/biopharmaceutical-stability- testing-market-3889 By Type (Monoclonal Antibodies & Antibody-Drug Conjugates, Recombinant Proteins, Vaccines, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, Academic & Government Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis Type Outlook (Revenue, USD Billion, 2022-2027)  Monoclonal Antibodies & Antibody-Drug Conjugates  Recombinant Proteins  Vaccines  Others End-User Type Outlook (Revenue, USD Billion, 2022-2027)  Pharmaceutical & Biopharmaceutical Companies  CMOs & CROs  Academic & Government Research Institutes Regional Outlook (Revenue, USD Billion, 2022-2027) North America  The U.S.  Canada  Mexico Europe  Germany  UK  France  Spain  Italy  Netherlands  Rest of Europe Asia Pacific  China  India  Japan  South Korea  Thailand  Indonesia  Malaysia  Singapore  Vietnam  Rest of APAC Central & South America  Brazil  Argentina  Chile  Rest of CSA Middle East & Africa  Saudi Arabia  UAE  Israel  South Africa  Rest of MEA Contact: Yash Jain Email address: [email protected] Phone Number: +1 6026667238